GAP Solutions, Inc. · 4 hours ago
Scientist (HIV-1 and HIV-2)
Bethesda, MD
Full-time
Onsite
Mid LevelGAP Solutions, Inc. is seeking a Scientist (HIV-1 and HIV-2) to support the Laboratory of Molecular Microbiology within the NIAID. The role involves creating and testing HIV virus stocks, developing protocols for human macrophage studies, and conducting research on HIV infection factors.
Management Consulting
Responsibilities
Create, test, and store HIV-1 and HIV-2 virus stocks taking into consideration established biosafety protocols
Develop and improve protocols for the processing and differentiation of primary human macrophages and their controlled infection by HIV-1 or HIV-2
Perform proteomics studies to identify novel host factors involved in the control of HIV infection
Validate newly identified host factors
Create stable cell lines expressing host restriction factors and/or knock out endogenous gene expression for the purpose of analyzing their effect on viral replication
Conduct research to study the role of nuclear pore proteins for nuclear import of HIV-1 capsids
Develop and apply molecular tools for confirming successful gene editing or inactivation
Maintain laboratory notebooks with sufficient details for reproducing results and documenting progress to support intellectual property evaluations
Maintain laboratory safety
Perform mandatory annual refresher training in lab safety and bio safety
Maintain accurate sample tracking and data management
Perform lab projects independently and assist other lab members with their tasks
Discuss and report data in peer reviewed papers and with the Federal Task Leader and scientists
Perform problem solving, call technical support to fix problems, initiate service calls or repairs, and interact with field service engineers and field application specialists for repair and optimization of laboratory equipment
Qualification
Required
Provide services as a Scientist (HIV-1 and HIV-2) in support of the overall functions of the Laboratory of Molecular Microbiology (LMM), Division of Intramural Research (DIR) within the National Institute of Allergy and Infectious Diseases (NIAID)
Create, test, and store HIV-1 and HIV-2 virus stocks taking into consideration established biosafety protocols
Develop and improve protocols for the processing and differentiation of primary human macrophages and their controlled infection by HIV-1 or HIV-2
Perform proteomics studies to identify novel host factors involved in the control of HIV infection
Validate newly identified host factors
Create stable cell lines expressing host restriction factors and/or knock out endogenous gene expression for the purpose of analyzing their effect on viral replication
Conduct research to study the role of nuclear pore proteins for nuclear import of HIV-1 capsids
Develop and apply molecular tools for confirming successful gene editing or inactivation
Maintain laboratory notebooks with sufficient details for reproducing results and documenting progress to support intellectual property evaluations
Maintain laboratory safety
Perform mandatory annual refresher training in lab safety and bio safety
Maintain accurate sample tracking and data management
Perform lab projects independently and assist other lab members with their tasks
Discuss and report data in peer reviewed papers and with the Federal Task Leader and scientists
Perform problem solving, call technical support to fix problems, initiate service calls or repairs, and interact with field service engineers and field application specialists for repair and optimization of laboratory equipment
Company
GAP Solutions, Inc.
GAP Solutions, Inc.
Founded in 1999
501-1000 employees
H1B Sponsorship
GAP Solutions, Inc. has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (11)
2024 (16)
2023 (6)
2022 (8)
2021 (6)
Funding
Current Stage
Late StageTotal Funding
unknown2017-12-06Acquired
Leadership Team
NICK GISMONDI
Executive Vice President & Chief Operating Officer
Recent News
2023-12-21
Company data provided by crunchbase